BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  ARCA biopharma Announces First Quarter 2023 Financial Results

  ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, reported first quarter 2023 financial results and provided a corporate update.

  April 24, 2023

   · 

  4 min read
• Pharm Country

  Vyant Bio Announces Voluntary Nasdaq Delisting and SEC Deregistration

  Vyant Bio, Inc. is a biotechnology company that incorporates innovative biology and data science to improve drug discovery for complex neurodevelopmental and neurodegenerative disorders.

  April 24, 2023

   · 

  5 min read
• BioForest

  Gilead Sciences Releases Inaugural ESG Impact Report

  Gilead Sciences recently released its inaugural Environmental, Social and Governance Impact Report.

  April 24, 2023

   · 

  1 min read
• Business

  Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer

  Tarsus Pharmaceuticals, Inc. today announced the appointment of Jeff Farrow as Chief Financial Officer and Chief Strategy Officer, effective immediately.

  April 24, 2023

   · 

  6 min read